Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)

  • John-Arne Røttingen mail,

    John-Arne.Rottingen@kunnskapssenteret.no

    Affiliations: Department of Health Management and Health Economics, Institute for Health and Society, University of Oslo, Oslo, Norway, Harvard Kennedy School, Harvard University, Cambridge, Massachusetts, United States of America

    X
  • Claudia Chamas

    Affiliation: Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil

    X
  • Published: May 15, 2012
  • DOI: 10.1371/journal.pmed.1001219

About the Authors

John-Arne Røttingen
Department of Health Management and Health Economics, Institute for Health and Society, University of Oslo, Oslo, Norway
John-Arne Røttingen
Harvard Kennedy School, Harvard University, Cambridge, Massachusetts, United States of America
Claudia Chamas
Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil

Corresponding Author

Email: John-Arne.Rottingen@kunnskapssenteret.no

Competing Interests

We have been Chair (J-AR) and Vice-Chair (CC) of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) at WHO. This Perspective reflects our views and not necessarily those of other CEWG members, our institutions, or WHO.

Author Contributions

Wrote the first draft of the manuscript: JAR. Contributed to the writing of the manuscript: JAR CC. ICMJE criteria for authorship read and met: JAR CC. Agree with manuscript results and conclusions: JAR CC.